Skip to main content
. 2021 Nov 15;2021(11):CD009286. doi: 10.1002/14651858.CD009286.pub4

ChiCTR1800019467.

Study name The effect and mechanism of fluoxetine on the automatic regulation of cerebral blood flow for ischemic stroke
Methods Study type: interventional (clinical trial)
Estimated enrolment:
Allocation: randomised
Intervention model: parallel assignment
Masking: unclear
Primary purpose: treatment
Participants China
Inclusion criteria
  • Age 30 to 80 years

  • First‐time acute (in the past 72 hours) ischaemic stroke

  • Diagnosis of stroke confirmed by imaging

  • Consent


Exclusion criteria
  • Haemorrhagic stroke

  • Coma

  • Massive cerebral infarction

  • Poor coordination of transcranial doppler ultrasonography

  • Currently participating or have participated in other clinical trials within 3 months

Interventions Experimental: 20 mg of fluoxetine daily for 90 days
Comparator: conventional therapy
Outcomes Baseline, 30 days after treatment, 90 days after treatment, 180 days after treatment
Automatic regulation of cerebral blood flow
Starting date  
Contact information  
Notes